We are live on ! Find out more
AFIB

Acutus Medical Inc
AFIB

Delisted

AFIB was delisted on the 8th of May, 2024.

Back to rankings

47 hedge funds and large institutions have $9.54M invested in Acutus Medical Inc in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% less funds holding

Funds holding: 65 → 47 (-18)

47% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 19

57% less capital invested

Capital invested by funds: $22.3M → $9.54M (-$12.7M)

58% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 26

75% less call options, than puts

Call options by funds: $57K | Put options by funds: $230K

Holders
47
Holders Change
-18
Holders Change %
-27.69%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
19
Closed
26
Calls
$57K
Puts
$230K
Net Calls
-$173K
Net Calls Change
+$16K

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$154K
2
AQR Capital Management
AQR Capital Management
Connecticut
+$134K
3
E
Ergoteles
New York
+$80.6K
4
TSS
Two Sigma Securities
New York
+$49.8K
5
Citadel Advisors
Citadel Advisors
Florida
+$45.1K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$872K
2
SM
Sabby Management
Florida
-$795K
3
Morgan Stanley
Morgan Stanley
New York
-$589K
4
GPCM
Granite Point Capital Management
Massachusetts
-$499K
5
State Street
State Street
Massachusetts
-$321K
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
26
Verition Fund Management
Connecticut
$22K +$17.1K +19,900 New
Wolverine Trading
27
Wolverine Trading
Illinois
$16K +$13.8K +16,072 New
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$15K +$11.6K +13,556 New
Citigroup
29
Citigroup
New York
$13K +$8.87K +10,339 +763%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$13K +$10.1K +11,765 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$12K -$42.3K -49,298 -82%
TRCT
32
Tower Research Capital (TRC)
New York
$12K +$3.44K +4,007 +56%
BCM
33
Bayesian Capital Management
New York
$12K +$9.16K +10,672 New
SAM
34
S.A. Mason
Michigan
$9K – – –
Federated Hermes
35
Federated Hermes
Pennsylvania
$6K +$756 +881 +22%
Fidelity Investments
36
Fidelity Investments
Massachusetts
$5K -$9.41K -10,960 -69%
Wells Fargo
37
Wells Fargo
California
$5K -$3.59K -4,182 -45%
UBS Group
38
UBS Group
Switzerland
$4K +$2.82K +3,284 +1,165%
O
39
OrbiMed
New York
$2.97K – – –
Bank of America
40
Bank of America
North Carolina
$1K -$7.97K -9,291 -93%
US Bancorp
41
US Bancorp
Minnesota
$1K – – –
WIM
42
Westside Investment Management
California
$19 +$2.58K +3,000 +21%
GPCM
43
Granite Point Capital Management
Massachusetts
– -$499K -359,333 Closed
Two Sigma Investments
44
Two Sigma Investments
New York
– -$276K -198,759 Closed
Two Sigma Advisers
45
Two Sigma Advisers
New York
– -$233K -167,700 Closed
BCM
46
Bridgeway Capital Management
Texas
– -$139K -100,000 Closed
OQS
47
Occudo Quantitative Strategies
Florida
– -$69K -49,941 Closed
N
48
Nuveen
North Carolina
– -$94K -49,162 Closed
Deutsche Bank
49
Deutsche Bank
Germany
– -$61K -44,012 Closed
Charles Schwab
50
Charles Schwab
California
– -$56K -39,813 Closed
1
2
3

AFIB Hedge Fund Activity: Q2 2022 in Review

47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q2 2022, worth a combined $9.54M — down 57% from $22.3M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of AFIB and 11 opened new positions — a net loss of 15 holders — while 19 trimmed existing stakes and 10 added.

The largest buyer was Clear Street, opening a new position worth an estimated $154K. The largest seller was BlackRock, cutting an estimated $872K.

  • 47 institutional investors held Acutus Medical Inc (AFIB) as of Q2 2022, down from 65 in Q1 2022.
  • Funds reported $9.54M of Acutus Medical Inc stock for Q2 2022, down 57% quarter-over-quarter.
  • 11 funds opened new Acutus Medical Inc positions in Q2 2022 and 26 closed out, a net change of -15 holders.
  • The largest Acutus Medical Inc buyer in Q2 2022 was Clear Street, an estimated $154K added.
  • The largest Acutus Medical Inc seller in Q2 2022 was BlackRock, an estimated $872K sold.

Based on aggregated 13F filings for Q2 2022.